Pharma

Your Article Summary

See Latest Articles

The risk of venous thromboembolism for drospirenone containing oral contraceptives is comparable to the risk of other oral contraceptives available on the market
BayNews International, 10/23/09

The Swiss regulatory authority Swissmedic has conducted an analysis with its expert medical committee on the latest data and studies regarding the risk of venous thromboembolism associated with oral hormonal contraceptives. The results of this analysis were announced earlier today by Swissmedic.

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/24/09

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09

Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09

 See all of Marketing/Media/ROI

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/24/09

Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
BayNews International, 11/24/09

Innovative polyurethane spray systems for district cooling
BayNews International, 11/24/09

 See all of Research & Development